# Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.

> **NCT02032797** · PHASE4 · COMPLETED · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 300 (actual)

## Conditions studied

- Cryopreservation
- Embryo Implantation
- Progesteron

## Interventions

- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT02032797
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02032797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02032797, "Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02032797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*